Neglected tropical diseases as hidden causes of cardiovascular disease

PLoS Neglected Tropical Diseases

Volumn 6, Issue 6, 2012, Pages

  Moolani, Yasmin ^a,c   Bukhman, Gene ^b   Hotez, Peter J ^c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN TRYPANOSOMIASIS; ARTICLE; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CHAGAS DISEASE; HEALTH CARE POLICY; HEART MUSCLE FIBROSIS; HOOKWORM INFECTION; HUMAN; LOWEST INCOME GROUP; NEGLECTED DISEASE; NEGLECTED TROPICAL DISEASES; PREVALENCE; RHEUMATIC HEART DISEASE; SCHISTOSOMIASIS; TROPICAL DISEASE; VIRUS INFECTION; EDITORIAL; PARASITOLOGY; PARASITOSIS; TROPIC CLIMATE;

CARDIOVASCULAR DISEASES; HUMANS; NEGLECTED DISEASES; PARASITIC DISEASES; PREVALENCE; TROPICAL CLIMATE;

EID: 84863703117     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001499     Document Type: Article

References (74)

1. Murray CJL, Lopez AD, (1996) Annex tables. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020: 553.
2. Leeder S, Raymond S, Greenberg H, (2004) A race against time. The challenge of cardiovascular diseases in developing economies. Available: http://www.earthinstitute.columbia.edu/news/2004/images/raceagainsttime_FINAL_051104.pdf. Accessed 24 May 2012.
3. World Health Organization (2011) Projections of mortality and burden of disease, 2004-2030; standard DALYs (3% discounting, age weights)- baseline scenario; 2008; WHO regions. Available: http://www.who.int/entity/healthinfo/global_burden_disease/DALY7_2008.xls. Accessed 25 May 2012.
4. World Health Organization (2005) Preventing chronic disease: a vital assessment. Available: http://www.who.int/chp/chronic_disease_report/en/. Accessed 25 May 2012.
5. Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, et al. (2011) The global economic burden of non-communicable diseases. Available: http://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf. Accessed 25 May 2012.
6. United Nations Web Services Section, Department of Public Information (2011) 2011 high level meeting on prevention and control of non-communicable diseases. Available: http://www.un.org/en/ga/ncdmeeting2011/. Accessed 25 May 2012.
7. Partners In Health (2011) The long tail of global health equity: tackling the endemic non-communicable diseases of the bottom billion. Available: http://www.pih.org/pages/harvardncd.
8. Commerford P, Mayosi B, (2006) An appropriate research agenda for heart disease in Africa. Lancet 367 (9526): 1884-1886.
9. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, et al. (2008) Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 371: 915-922.
10. World Health Organization (2011) Chagas disease (American trypanosomiasis). Available: http://www.who.int/mediacentre/factsheets/fs340/en/index.html. Accessed 25 May 2012.
11. Yacoub S, Mocumbi AO, Yacoub MH, (2008) Neglected tropical cardiomyopathies: I. Chagas disease. Heart 94 (2): 244-248.
12. Benvenuti LA, Roggério A, Freitas HFG, Mansur AJ, Fiorelli A, et al. (2008) Chronic american trypanosomiasis: parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis. Ann Trop Med Parasitol 102 (6): 481-487.
13. Paixão LC, Ribeiro AL, Valacio RA, Teixeira AL, (2009) Chagas disease: independent risk factor for stroke. Stroke 40 (12): 3691-3694.
14. Sambiase NV, Higuchi ML, Benvenuti LA, (2010) Narrowed lumen of the right coronary artery in chronic chagasic patients is associated with ischemic lesions of segmental thinnings of ventricles. Invest Clin 51 (4): 531-539 Available: http://www.scielo.org.ve/pdf/ic/v51n4/art09.pdf. Accessed 25 May 2012.
15. Schmunis GA, Yadon ZE, (2010) Chagas disease: A Latin American health problem becoming a world health problem. Acta Trop 115 (1-2): 14-21.
16. Barratt JLN, Harkness J, Marriott D, Ellis JT, Stark D, (2010) Importance of nonenteric protozoan infections in immunocompromised people. Clin Microbiol Rev 23 (4): 795-836.
17. Carod-Artal FJ, (2010) Trypanosomiasis, cardiomyopathy and the risk of ischemic stroke. Expert Rev Cardiovasc Ther 8 (5): 717-728.
18. Hotez PJ, Kamath A, (2009) Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 3 (8): e412 doi:10.1371/journal.pntd.0000412.
19. Mocumbi AO, Ferreira MB, Sidi D, Yacoub MH, (2008) A population study of endomyocardial fibrosis in a rural area of mozambique. N Engl J Med 359 (1): 43-49.
20. Mocumbi AO, Yacoub S, Yacoub MH, (2008) Neglected tropical cardiomyopathies: II. Endomyocardial fibrosis. Heart 94 (3): 384-390.
21. Sovari AA, Kocheril AG, (2010) Endomyocardial fibrosis. (1/21). Available: http://emedicine.medscape.com/article/154931-overview#a0199. Accessed 25 May 2012.
22. Andy JJ, Ogunowo PO, Akpan NA, Odigwe CO, Ekanem IA, et al. (1998) Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria. Acta Trop 69 (2): 127-140.
23. Franco-Paredes C, Rouphael N, Méndez J, Folch E, Rodríguez-Morales AJ, et al. (2007) Cardiac manifestations of parasitic infections part 3: pericardial and miscellaneous cardiopulmonary manifestations. Clin Cardiol 30 (6): 277-280.
24. Berenguer A, Plancha E, Gil JM, (2003) Right ventricular endomyocardial fibrosis and microfilarial infection. Int J Cardiol 87 (2-3): 287-289.
25. Ive FA, Willis AJ, Ikeme AC, Brockington IF, (1967) Endomyocardial fibrosis and filariasis. Q J Med 36 (144): 495-516.
26. Nutman TB, Miller KD, Mulligan M, Ottesen EA, (1986) Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations. J Infect Dis 154 (1): 10-18.
27. Bukhman G, Ziegler J, Parry E, (2008) Endomyocardial fibrosis: still a mystery after 60 years. PLoS Negl Trop Dis 2 (2): e97 doi:10.1371/journal.pntd.0000097.
28. Cheever AW, Kamel IA, Elwi AM, (1978) Schistosoma mansoni and S. haematobium infections in Egypt. III. extrahepatic pathology. Am J Trop Med Hyg 27 (1 I): 55-75.
29. De Cleva R, Herman P, Pugliese V, Zilberstein B, Saad WA, et al. (2003) Prevalence of pulmonary hypertension in patients with hepatosplenic mansonic schistosomiasis- prospective study. Hepatogastroenterology 50 (54): 2028-2030.
30. Morris W, Knauer CM, (1997) Cardiopulmonary manifestations of schistosomiasis. Semin Respir Infect 12 (2): 159-170.
31. Mocumbi AOH, Ferreira MB, (2010) Neglected cardiovascular diseases in Africa. Challenges and opportunities. J Am Coll Cardiol 55 (7): 680-687.
32. Lapa M, Dias B, Jardim C, Fernandes CJC, Dourado PMM, et al. (2009) Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation 119 (11): 1518-1523.
33. King CH, (2010) Parasites and poverty: the case of schistosomiasis. Acta Trop 113 (2): 95-104.
34. Van Der Werf MJ, De Vlas SJ, Brooker S, Looman CWN, Nagelkerke NJD, et al. (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86 (2-3): 125-139.
35. Hotez PJ, Brooker S, Bethony JM, Bottazzi ME, Loukas A, et al. (2004) Hookworm infection. N Engl J Med 351 (8): 799-807+841.
36. Brooker S, Hotez PJ, Bundy DAP, (2008) Hookworm-related anaemia among pregnant women: a systematic review. PLoS Negl Trop Dis 2 (9): 291 doi:10.1371/journal.pntd.0000291.
37. Smith JL, Brooker S, (2010) Impact of hookworm infection and deworming on anaemia in non-pregnant populations: a systematic review. Trop Med Int Health 15 (7): 776-795.
38. Hotez PJ, Bethony JM, Diemert DJ, Pearson M, Loukas A, (2010) Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat Rev Microbiol 8 (11): 814-826.
39. World Health Organization (2010) First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases. Available http://www.who.int/neglected_diseases/2010report/en/. Accessed 25 May 2012.
40. World Health Organization (2001) Global prevalence and incidence of selected curable sexually transmitted infections: overview of estimates. Available: http://www.who.int/reproductivehealth/publications/rtis/HIV_AIDS_2001_2/en/index.html. Accessed 25 May 2012.
41. Vaideeswar P, (2010) Syphilitic aortitis: rearing of the ugly head. Indian J Pathol Microbiol 53 (4): 624-627.
42. Leach W, (1960) Case report: gummatous myocarditis. Br Heart J 22: 149-152.
43. Jackman JD Jr, Radolf JD, (1989) Cardiovascular syphilis. Am J Med 87 (4): 425-433.
44. Cegielski JP, Ramiya K, Lallinger GJ, Mtulia IA, Mbaga IM, (1990) Pericardial disease and human immunodeficiency virus in Dar es Salaam, Tanzania. Lancet 335: 209-212.
45. Mayosi BM, Volmink JA, Commerford PJ, (2007) Pericardial disease: an evidence-based approach to diagnosis and treatment. In: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, editors. Evidence-based cardiology. Second edition London BMJ Books editors.
46. Larrieu AJ, Tyers GFO, Williams EH, Derrick JR, (1980) Recent experience with tuberculous pericarditis. Ann Thorac Surg 29 (5): 464-468.
47. Trautner BW, Darouiche RO, (2001) Tuberculous pericarditis: optimal diagnosis and management. Clin Infect Dis 33 (7): 954-961.
48. Mayosi BM, Wiysonge CS, Ntsekhe M, Gumedze F, Volmink JA, et al. (2008) Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. S Afr Med J 98 (1): 36-40.
49. Ntsekhe M, Mayosi BM, (2009) Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med 6 (2): 120-127.
50. Magula NP, Mayosi BM, (2003) Cardiac involvement in HIV-infected people living in africa: a review. Cardiovasc J S Afr 14 (5): 231-237.
51. Carapetis JR, Steer AC, Mulholland EK, Weber M, (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5 (11): 685-694.
52. Carapetis JR, (2007) Rheumatic heart disease in developing countries. N Engl J Med 357 (5): 439-441.
53. Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, et al. (2007) Prevalence of rheumatic heart disease detected by echocardiographic screening. New Engl J Med 357 (5): 470-476.
54. Yacoub S, Griffiths A, Chau TTH, Simmons CP, Wills B, et al. (2011) Cardiac function in Vietnamese patients with different dengue severity grades. Crit Care Med 40 (2): 477-483.
55. Lee IK, Lee WH, Liu JW, Yang KD, (2010) Acute myocarditis in dengue hemorrhagic fever: A case report and review of cardiac complications in dengue-affected patients. Int J Infect Dis 14 (10): e919-e922.
56. Salgado DM, Eltit JM, Mansfield K, Panqueba C, Castro D, et al. (2010) Heart and skeletal muscle are targets of dengue virus infection. Pediatr Infect Dis J 29 (3): 238-242.
57. Carapetis JR, Zuhlke LJ, (2011) Global research priorities in rheumatic fever and rheumatic heart disease. Ann Pediatr Card 4 (1): 4-12.
58. Yacoub S, Kotit S, Mocumbi AO, Yacoub MH, (2008) Neglected diseases in cardiology: a call for urgent action. Nat Clin Pract Cardiovasc Med 5 (4): 176-177.
59. Centers for Disease Control and Prevention (2010) Chagas disease- resources for health professionals- diagnosis. Available: http://www.cdc.gov/parasites/chagas/health_professionals/dx.html. Accessed 25 May 2012.
60. Bukhman G, Kidder A, (2008) Cardiovascular disease and global health equity: lessons from tuberculosis control then and now. Am J Public Health 98: 44-54.
61. Bukhman G, Kidder A, eds. (2010) The Partners In Health guide to chronic care integration for endemic non-communicable diseases- Rwanda edition. Partners In Health. eds. (Available: http://www.pih.org/publications/entry/the-pih-guide-to-chronic-care-integration-for-endemic-ncd. Accessed 25 May 2012.
62. Hotez PJ, Pecoul B, (2010) "Manifesto" for advancing the control and elimination of neglected tropical diseases. PLoS Negl Trop Dis 4 (5): e718 doi:10.1371/journal.pntd.0000718.
63. Lannes-Vieira J, de Araújo-Jorge TC, de Nazaré Correia Soeiro M, Gadelha P, Corrêa-Oliveira R, (2010) The centennial of the discovery of chagas disease: facing the current challenges. PLoS Negl Trop Dis 4 (6): e645 doi:10.1371/journal.pntd.0000645.
64. Hotez PJ, Dumonteil E, Heffernan MJ, Bottazzi ME, Innovation for the "bottom billion": eliminating neglected tropical diseases in the Americas through mass drug administration and new vaccines for hookworm and Chagas disease. Adv Exp Med Biol In press.
65. Aeras Global TB Vaccine Foundation (2010) Aeras annual report 2011: answering the call for a TB free world. Available: http://www.aeras.org/annualreport2010/. Accessed 25 May 2012.
66. Kaufmann SHE, (2000) Is the development of a new tuberculosis vaccine possible? Nat Med 6 (9): 955-960.
67. Tenter AM, Heckeroth AR, Weiss LM, (2000) Toxoplasma gondii: from animals to humans. Int J Parasitol 30 (12-13): 1217-1258.
68. Longo-Mbenza B, Seghers KV, Phuati M, Nkiabungu Bikangi F, Mubagwa K, (1998) Heart involvement and HIV infection in African patients: determinants of survival. Int J Cardiol 64 (1): 63-73.
69. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, et al. (2007) Control of neglected tropical diseases. N Engl J Med 357 (10): 1018-1027.
70. Harrison LW, (1956) The Oslo study of untreated syphilis, review and commentary. Br J Vener Dis 32 (2): 70-78 doi:10.1136/sti.32.2.70.
71. World Health Organization (1999) The world health report 1999- making a difference. Available: http://www.who.int/whr/1999/en/index.html. Accessed 25 May 2012.
72. [No authors listed] (2000) TDR research on dengue: recommendations of a scientific working group. June 2000. TDR News 62 pp. 3, 15.
73. Khongphatthanayothin A, Lertsapcharoen P, Supachokchaiwattana P, La-orkhun V, Khumtonvong A, et al. (2007) Myocardial depression in dengue hemorrhagic fever: prevalence and clinical description. Pediatr Crit Care Med 8 (6): 524-529.
74. Eisenberg MJ, (1993) Rheumatic heart disease in the developing world: prevalence, prevention, and control. Eur Heart J 14 (1): 122-128.